An explanation for the activation of CAR-T cells shown by increased expression of CD137 and followed by elevation of CD107a and IFN-γ might be the up-regulated target antigen CD19 on tumor cells by BH3 mimetic treatment leading to an enhanced signal I of activation in CD19.CAR-T cells. This evidence concerns the gene CD19 and neoplasm.